Free Trial

Balchem (BCPC) Stock Price, News & Analysis

Balchem logo
$145.53 +1.90 (+1.32%)
Closing price 03:59 PM Eastern
Extended Trading
$145.19 -0.34 (-0.23%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Balchem Stock (NASDAQ:BCPC)

Advanced

Key Stats

Today's Range
$142.83
$146.30
50-Day Range
$140.30
$165.12
52-Week Range
$139.17
$185.96
Volume
127,673 shs
Average Volume
164,636 shs
Market Capitalization
$4.72 billion
P/E Ratio
33.38
Dividend Yield
0.60%
Price Target
$189.00
Consensus Rating
Hold

Company Overview

Balchem Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
93rd Percentile Overall Score

BCPC MarketRank™: 

Balchem scored higher than 93% of companies evaluated by MarketBeat, and ranked 6th out of 192 stocks in the basic materials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Balchem has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.

  • Upside Potential

    Balchem has a consensus price target of $189.00, representing about 29.9% upside from its current price of $145.53.

  • Amount of Analyst Coverage

    Balchem has only been the subject of 2 research reports in the past 90 days.

  • Read more about Balchem's stock forecast and price target.
  • Earnings Growth

    Earnings for Balchem are expected to grow by 10.99% in the coming year, from $4.64 to $5.15 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Balchem is 33.38, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 233.20.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Balchem is 33.38, which means that it is trading at a less expensive P/E ratio than the Basic Materials sector average P/E ratio of about 160.09.

  • Price to Earnings Growth Ratio

    Balchem has a PEG Ratio of 3.04. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Balchem has a P/B Ratio of 4.11. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Balchem's valuation and earnings.
  • Percentage of Shares Shorted

    1.35% of the float of Balchem has been sold short.
  • Short Interest Ratio / Days to Cover

    Balchem has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Balchem has recently increased by 2.28%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Balchem has a dividend yield of 0.61%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Balchem has been increasing its dividend for 16 years.

  • Dividend Coverage

    The dividend payout ratio of Balchem is 19.95%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Balchem will have a dividend payout ratio of 16.89% next year. This indicates that Balchem will be able to sustain or increase its dividend.

  • Read more about Balchem's dividend.
  • Percentage of Shares Shorted

    1.35% of the float of Balchem has been sold short.
  • Short Interest Ratio / Days to Cover

    Balchem has a short interest ratio ("days to cover") of 2.6, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Balchem has recently increased by 2.28%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Balchem has a news sentiment score of 1.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Basic Materials companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Balchem this week, compared to 1 article on an average week.
  • Search Interest

    Only 1 people have searched for BCPC on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Balchem insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.39% of the stock of Balchem is held by insiders.

  • Percentage Held by Institutions

    87.91% of the stock of Balchem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Balchem's insider trading history.
Receive BCPC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Balchem and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BCPC Stock News Headlines

Is *BSEM* Oversold??
BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The company delivered record-breaking revenues in 2024 and Q1 2025, including $72.5 million in net revenue for Q1 — a 73% increase over the prior year — and six consecutive quarters of positive adjusted EBITDA. With cash reserves rising to $30.8 million and a growing patent portfolio of 58 issued and 68 pending patents, BSEM is scaling profitably while advancing its proprietary BioREtain® technology, which has shown clinically superior results for chronic, non-healing wounds. National recognition is adding to the momentum, with CEO Jason Matuszewski named EY Entrepreneur of the Year 2025 Florida Award winner, validating the leadership driving this high-growth MedTech powerhouse.tc pixel
Is Now The Time To Put Balchem (NASDAQ:BCPC) On Your Watchlist?
See More Headlines

BCPC Stock Analysis - Frequently Asked Questions

Balchem's stock was trading at $162.99 at the beginning of 2025. Since then, BCPC shares have decreased by 10.7% and is now trading at $145.5320.

Balchem Corporation (NASDAQ:BCPC) issued its quarterly earnings data on Thursday, July, 31st. The basic materials company reported $1.27 EPS for the quarter, beating the consensus estimate of $1.25 by $0.02. The company's revenue for the quarter was up 9.1% on a year-over-year basis.
Read the conference call transcript
.

Balchem subsidiaries include Zumbro River Brand Inc., Chemogas Holding NV, Bioscreen technologies, Innovative Food Processors, Chol-Mix Kft, Albion Laboratories Inc., SensoryEffects, and more.

Balchem's top institutional shareholders include Congress Asset Management Co. (1.15%), Assenagon Asset Management S.A. (0.86%), Bath Savings Trust Co (0.10%) and Voya Investment Management LLC (0.08%). Insiders that own company stock include Theodore L Harris, David B Fischer, Gunsteren Job Leonard Van, William A Backus and Michael Robert Sestrick.
View institutional ownership trends
.

Shares of BCPC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Balchem investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE), Arista Networks (ANET) and ServiceNow (NOW).

Company Calendar

Last Earnings
7/31/2025
Today
10/16/2025
Next Earnings (Estimated)
10/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
CHEM - SPECIALTY
Sub-Industry
Specialty Chemicals
Current Symbol
NASDAQ:BCPC
Previous Symbol
NASDAQ:BCPC
CIK
9326
Employees
1,361
Year Founded
1967

Price Target and Rating

High Price Target
$189.00
Low Price Target
$189.00
Potential Upside/Downside
+31.6%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
$4.36
Trailing P/E Ratio
32.94
Forward P/E Ratio
30.95
P/E Growth
3.04
Net Income
$128.48 million
Net Margins
14.48%
Pretax Margin
18.80%
Return on Equity
12.41%
Return on Assets
9.21%

Debt

Debt-to-Equity Ratio
0.17
Current Ratio
2.64
Quick Ratio
1.57

Sales & Book Value

Annual Sales
$953.68 million
Price / Sales
4.89
Cash Flow
$5.48 per share
Price / Cash Flow
26.22
Book Value
$35.37 per share
Price / Book
4.06

Miscellaneous

Outstanding Shares
32,460,000
Free Float
32,004,000
Market Cap
$4.66 billion
Optionable
Optionable
Beta
0.92

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:BCPC) was last updated on 10/16/2025 by MarketBeat.com Staff
From Our Partners